U.S. markets open in 1 hour 58 minutes

Amgen Inc. (AMGN.BA)

Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
4,423.00-36.00 (-0.81%)
At close: 4:35PM ART
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4,459.00
Open4,447.00
Bid4,415.00 x N/A
Ask4,448.00 x N/A
Day's Range4,410.50 - 4,447.00
52 Week Range360.50 - 4,447.00
Volume30
Avg. Volume0
Market Cap166.515T
Beta (5Y Monthly)0.71
PE Ratio (TTM)105.59
EPS (TTM)41.89
Earnings DateN/A
Forward Dividend & Yield5.70 (1.58%)
Ex-Dividend DateMay 14, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Healthcare ETFs in Focus as Q2 Earnings Unfold
      Zacks

      Healthcare ETFs in Focus as Q2 Earnings Unfold

      The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come.

    • Amgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO
      Bloomberg

      Amgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO

      (Bloomberg) -- Hummingbird Bioscience, a Singaporean clinical-stage biotechnology firm, is considering fundraising options including an initial public offering, according to people familiar with the matter.The company is interviewing investment banks as it weighs alternatives, which also include a private funding round, the people said, asking not to be identified because the matter is private.Hummingbird could seek to raise about $200 million to $300 million in a share sale, which could take pl

    • How Much Of Amgen Inc. (NASDAQ:AMGN) Do Institutions Own?
      Simply Wall St.

      How Much Of Amgen Inc. (NASDAQ:AMGN) Do Institutions Own?

      If you want to know who really controls Amgen Inc. ( NASDAQ:AMGN ), then you'll have to look at the makeup of its share...